According to a DARA regulatory filing, Uman is responsible for formulation, analytical and manufacturing work on the drug. Uman must also make the abbreviated new drug application for U.S. marketing ...
The cancer products portfolio that DARA BioSciences (NASDAQ:DARA) has been building by acquisition now has more than $9 million in fresh capital to help bring those products to market. The ...
DARA BioSciences Establishes Vertically Integrated Commercial Platform for Specialty Oncology Care a
RALEIGH, N.C.--(BUSINESS WIRE)-- DARA BioSciences, Inc. (NAS: DARA) , a specialty pharmaceutical company focused on oncology and oncology support products, announced today it has a completed a series ...
RALEIGH, N.C.--(BUSINESS WIRE)-- DARA BioSciences, Inc. (NAS: DARA) (the "Company" or "DARA") announced that it entered into a definitive securities purchase agreement with certain investors providing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback